Trevena Inc (NASDAQ:TRVN)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - TRVN
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - TRVN
- Market Cap$347.040m
- SymbolNASDAQ:TRVN
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS89532E1091
Company Profile
Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain.Trevena Inc is a clinical stage biopharmaceutical company. It discovers, develops and commercialize therapeutics that use a novel approach to target G protein coupled receptors.
Latest TRVN news
Currently there for this company. Visit our news hub for other news .